The global molecular diagnostics market features a highly consolidated vendor landscape, with the top three players, namely F. Hoffmann-La Roche Ltd., Abbott Laboratories, and Danaher Corporation, representing over 54% of the overall market. The dominance of these players can be attributed to their broad product portfolio, finds Transparency Market Research (TMR) in a study. “Several players are going the mergers and acquisitions routes to stay ahead of the curve. For instance, Danaher acquired Cepheid in 2016 which is poised to the operational efficiencies and expand their diagnostic units,” says TMR’s lead analyst.
Well-established Healthcare Infrastructure behind North America’s Dominance
The valuation of the global US$7.10 bn in 2016 and is estimated to reach US$18.98 bn by 2024, exhibiting a CAGR of 11.6% from 2017 to 2025. On the basis of end user, diagnostic laboratories will continue to dominate the market until 2025, accounting for 38.5% of the overall market value. The availability of well-equipped and sophisticated instruments in diagnostic labs make them a preferred choice for diagnosis. The segment is expected to register a strong growth during the forecast period.
Geographically, North America will continue to be at the forefront of growth until 2025. Changing demographics, growing incidence of cancer, and well-established healthcare infrastructure are contributing to the dominance of the region. Asia Pacific is anticipated to post a noteworthy CAGR of 12.2% during the same period, owing to the improving healthcare infrastructure and the increasing acceptance of technologically advanced products.
Growing Incidence of Cancer and Infectious Diseases Boosts Demand for Molecular Diagnostics
Governments worldwide are allocating significant budgets to the healthcare sector, which in turn influences diagnostics healthcare. For instance, in 2015, the overall share of the U.S. economy devoted to health care spending was 17.8%. Therefore, the increasing government funding is augmenting the global molecular diagnostics market. Moreover, the growing inclination towards personalized medicines is translating into the greater uptake of molecular diagnostics worldwide.
Another important factor stoking the global market is the rising prevalence of infectious diseases and cancer. “Expanding base of patients suffering from cancer is creating a soaring need for efficient and target-specific medicines, which in turn is triggering the demand for personalized medicines,” says a TMR analyst. The trailblazing researches in the field of biomarkers are also working in favor of the market. Furthermore, continuous advancements in technology, growing global geriatric population, and improving consumer expending power on healthcare are providing a fillip to the market.
Complex Regulatory Framework Inhibits Growth Prospects
The complex regulatory scenario is leading to delays in the introduction of new treatments and also makes them expensive, which in turn is negatively impacting the growth of the global molecular diagnostics market. “Insurance companies are refraining from reimbursing molecular diagnostic tests due to lack of appropriate coding system,” says an analyst. This is leading to unfavorable reimbursement scenario, thereby negatively impacting the growth of the market. Moreover, the lack of awareness and ambiguities related to molecular diagnostics are adversely affecting the growth of the market.
The above data has been derived from a report by TMR, titled “Molecular Diagnostics Market (Technology - PCR and Real-Time PCR, Hybridization, Microarray, Transcription-mediated Amplification, and Next-Generation Sequencing; Application - Infectious Diseases, Oncology, Blood Screening, Microbiology, Genetic Testing, and Women’s Health; End User: Hospitals, Diagnostic Laboratories, Blood Banks, Academics, and Research) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025.”
The global molecular diagnostics market is segmented as given below:
Global Molecular Diagnostics Market, by Technology
- PCR and Real-Time PCR
- Transcription-Mediated Amplification
- Next-Generation Sequencing
- Others (Mass Spectrometry, etc.)
Global Molecular Diagnostics Market, by Application
- Infectious Diseases
- Blood Screening
- Genetic Testing
- Women’s Health
Global Molecular Diagnostics Market, by End Use
- Diagnostic Laboratories
- Blood Banks
Global Molecular Diagnostics Market, by Region
- North America
- Rest of Europe
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
7 of 10 large enterprizes view our ToC to take the right decision.View Report ToC